secwatch / observer
8-K filed February 8, 2023, 6:59 PM ET ticker PALI CIK 0001357459
leadership confidence high sentiment neutral materiality 0.50

Palisade Bio promotes Robert McRae to COO, appoints J.D. Finley to Board

PALISADE BIO, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert McRae

Chief Operating Officer
PALI · PALISADE BIO, INC.
Effective
2023-02-02
Filed
February 8, 2023, 6:59 PM ET
On February 2, 2023, the Company appointed Robert McRae as the Company’s Chief Operating Officer.
Appointed

J.D. Finley

Director
PALI · PALISADE BIO, INC.
Effective
2023-02-02
Filed
February 8, 2023, 6:59 PM ET
On February 2, 2023, the Board appointed J.D. Finley to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert McRae was appointed as Chief Operating Officer at PALISADE BIO, INC..

Action
appointed
Role
Chief Operating Officer
Exact text from the filing
On February 2, 2023, the Company appointed Robert McRae as the Company’s Chief Operating Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

J.D. Finley was appointed as Director at PALISADE BIO, INC..

Action
appointed
Role
Director
Exact text from the filing
On February 2, 2023, the Board appointed J.D. Finley to the Board.
View on SEC.gov

PALISADE BIO, INC. filing history →

Source: SEC EDGAR
accession 0001493152-23-003966
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.